ARK Funds(@ARK_Funds):The headline: an AI-designed, personalized cancer vaccine succeeded in a major clinical trial. It’s the first time an mRNA cancer treatment has pulled that off. Here's why it matters to us. A year ago, this problem looked like hundreds of others in medicine: genetically complex, buried in data, nobody had cracked it. Now, there's proof in the approach. That's the real story. It's also the thesis behind the ARK Genomic Revolution ETF $ARKG, that AI and genomics are just starting to come together, and most of what that produces is still ahead of us. What next breakthrough will AI solve in healthcare? Companies we believe are leading the way:

2026.10.26 14:19

The headline: an AI-designed, personalized cancer vaccine succeeded in a major clinical trial. It’s the first time an mRNA cancer treatment has pulled that off. Here's why it matters to us. A year ago, this problem looked like hundreds of others in medicine: genetically complex, buried in data, nobody had cracked it. Now, there's proof in the approach. That's the real story. It's also the thesis behind the ARK Genomic Revolution ETF $ARKG, that AI and genomics are just starting to come together, and most of what that produces is still ahead of us. What next breakthrough will AI solve in healthcare? Companies we believe are leading the way: